CI
DXCM icon

Cigna Investments’s DexCom DXCM Stock Holding History

Cigna Investments’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$250K Hold
3,709
– – 0.03% 406
2026
Q1 		$232K Sell
3,709
-152
-4% -$10.6K 0.04% 412
2025
Q4 		$257K Hold
3,861
– – 0.04% 389
2025
Q3 		$260K Hold
3,861
– – 0.04% 382
2025
Q2 		$338K Sell
3,861
-56
-1% -$4.39K 0.06% 316
2025
Q1 		$268K Sell
3,917
-57
-1% -$4.65K 0.05% 359
2024
Q4 		$309K Hold
3,974
– – 0.05% 341
2024
Q3 		$266K Sell
3,974
-88
-2% -$7.23K 0.05% 376
2024
Q2 		$460K Sell
4,062
-40
-1% -$5.06K 0.09% 222
2024
Q1 		$569K Sell
4,102
-41
-1% -$5.15K 0.11% 193
2023
Q4 		$514K Sell
4,143
-39
-0.9% -$3.98K 0.11% 193
2023
Q3 		$390K Sell
4,182
-535
-11% -$60.3K 0.09% 239
2023
Q2 		$606K Hold
4,717
– – 0.11% 172
2023
Q1 		$548K Sell
4,717
-137
-3% -$15.3K 0.11% 194
2022
Q4 		$550K Sell
4,854
-31
-0.6% -$3.4K 0.11% 188
2022
Q3 		$393K Sell
4,885
-111
-2% -$9.4K 0.09% 248
2022
Q2 		$372K Sell
4,996
-1,840
-27% -$168K 0.07% 275
2022
Q1 		$875K Sell
6,836
-1,968
-22% -$215K 0.11% 181
2021
Q4 		$1.18M Sell
8,804
-3,320
-27% -$477K 0.09% 171
2021
Q3 		$1.66M Buy
12,124
+120
+1% +$15.1K 0.12% 148
2021
Q2 		$1.28M Sell
12,004
-2,024
-14% -$194K 0.09% 191
2021
Q1 		$1.26M Buy
14,028
+536
+4% +$50.3K 0.09% 213
2020
Q4 		$1.25M Buy
13,492
+1,128
+9% +$101K 0.1% 180
2020
Q3 		$1.27M Sell
12,364
-512
-4% -$53.5K 0.12% 153
2020
Q2 		$1.3M Buy
12,876
+7,908
+159% +$707K 0.12% 157
2020
Q1 		$335K Buy
4,968
+1,228
+33% +$76.4K 0.04% 423
2019
Q4 		$225K Buy
+3,740
New +$177K 0.02% 596

Other funds holding DXCM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Cigna Investments's DXCM Position: Q2 2026 in Review

Cigna Investments held its DexCom (DXCM) position steady in Q2 2026 at 3,709 shares worth $250K. The position accounts for 0.03% of the portfolio, ranked #406.

Cigna Investments first reported a position in DXCM in Q4 2019 and has held it in 27 quarters since. The position peaked at $1.66M in Q3 2021. 968 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Cigna Investments held 3,709 shares of DexCom worth $250K as of Q2 2026.
  • Cigna Investments left its DexCom share count unchanged in Q2 2026.
  • DexCom made up 0.03% of Cigna Investments's portfolio in Q2 2026, its #406 holding.
  • Cigna Investments first reported a position in DexCom in Q4 2019 and has held it in 27 quarters since.
  • Cigna Investments's DexCom position peaked at $1.66M in Q3 2021.
  • 968 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Cigna Investments's 13F filing for Q2 2026, filed 21 Jul 2026.